Eagle Pharmaceuticals Stock Price on May 17, 2024
| EGRX Stock | USD 3.47 0.04 1.17% |
Below is the normalized historical share price chart for Eagle Pharmaceuticals extending back to February 12, 2014. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Eagle Pharmaceuticals stands at 3.47, as last reported on the 1st of June, with the highest price reaching 3.52 and the lowest price hitting 3.26 during the day.
If you're considering investing in Eagle Stock, it is important to understand the factors that can impact its price. Eagle Pharmaceuticals secures Sharpe Ratio (or Efficiency) of -0.17, which denotes the company had a -0.17% return per unit of risk over the last 3 months. Eagle Pharmaceuticals exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Eagle Pharmaceuticals' Standard Deviation of 5.03, variance of 25.25, and Mean Deviation of 3.76 to check the risk estimate we provide.
At this time, Eagle Pharmaceuticals' Liabilities And Stockholders Equity is fairly stable compared to the past year. Stock Based Compensation To Revenue is likely to rise to 0.06 in 2024, whereas Total Stockholder Equity is likely to drop slightly above 138 M in 2024. . At this time, Eagle Pharmaceuticals' Price To Operating Cash Flows Ratio is fairly stable compared to the past year. Price To Free Cash Flows Ratio is likely to rise to 7.07 in 2024, whereas Price To Sales Ratio is likely to drop 1.30 in 2024. Eagle Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 12th of February 2014 | 200 Day MA 8.4841 | 50 Day MA 4.5817 | Beta 0.462 |
Eagle |
Sharpe Ratio = -0.1682
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | EGRX |
Estimated Market Risk
| 4.88 actual daily | 43 57% of assets are more volatile |
Expected Return
| -0.82 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.17 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Eagle Pharmaceuticals is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Eagle Pharmaceuticals by adding Eagle Pharmaceuticals to a well-diversified portfolio.
Price Book 0.236 | Enterprise Value Ebitda 2.0711 | Price Sales 0.2309 | Shares Float 9 M | Wall Street Target Price 17 |
Related Headline
Phio Pharmaceuticals Headline on 17th of May 2024
Phio Pharmaceuticals Secures New Investor by globenewswire.com
--Fund invests in microcap equities...
Eagle Pharmaceuticals Valuation on May 17, 2024
It is possible to determine the worth of Eagle Pharmaceuticals on a given historical date. On May 17, 2024 Eagle was worth 4.71 at the beginning of the trading date compared to the closed value of 4.76. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Eagle Pharmaceuticals stock. Still, in general, we apply an absolute valuation method to find Eagle Pharmaceuticals' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Eagle Pharmaceuticals where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Eagle Pharmaceuticals' related companies.
| Open | High | Low | Close | Volume | |
| 4.82 | 4.82 | 4.50 | 4.75 | 125,668 | |
05/17/2024 | 4.71 | 4.98 | 4.69 | 4.76 | 68,384 |
| 4.78 | 4.78 | 4.54 | 4.61 | 45,924 |
| Backtest Eagle Pharmaceuticals | | | Eagle Pharmaceuticals History | | | Eagle Pharmaceuticals Valuation | Previous | Next |
Eagle Pharmaceuticals Trading Date Momentum on May 17, 2024
| On May 20 2024 Eagle Pharmaceuticals was traded for 4.61 at the closing time. The top price for the day was 4.78 and the lowest listed price was 4.54 . The trading volume for the day was 45.9 K. The trading history from May 20, 2024 was a factor to the next trading day price decrease. The overall trading delta against the next closing price was 3.15% . The overall trading delta against the current closing price is 19.75% . |
Eagle Pharmaceuticals Fundamentals Correlations and Trends
By evaluating Eagle Pharmaceuticals' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Eagle Pharmaceuticals' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Eagle financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Eagle Pharmaceuticals Stock history
Eagle Pharmaceuticals investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Eagle is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Eagle Pharmaceuticals will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Eagle Pharmaceuticals stock prices may prove useful in developing a viable investing in Eagle Pharmaceuticals
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 15 M | 14.9 M | |
| Net Income Applicable To Common Shares | 41 M | 24.6 M |
Eagle Pharmaceuticals Quarterly Net Working Capital |
|
Eagle Pharmaceuticals Stock Technical Analysis
Eagle Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Eagle Pharmaceuticals Period Price Range
Low | May 17, 2024
| High |
4.71 | 4.76 |
Eagle Pharmaceuticals June 1, 2024 Market Strength
Market strength indicators help investors to evaluate how Eagle Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Eagle Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying Eagle Pharmaceuticals stock market strength indicators, traders can identify Eagle Pharmaceuticals entry and exit signals to maximize returns
| Accumulation Distribution | 3982.2 | |||
| Daily Balance Of Power | 0.1724 | |||
| Rate Of Daily Change | 1.01 | |||
| Day Median Price | 4.84 | |||
| Day Typical Price | 4.81 | |||
| Price Action Indicator | (0.05) | |||
| Period Momentum Indicator | (1.29) |
Eagle Pharmaceuticals Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Eagle Pharmaceuticals' price direction in advance. Along with the technical and fundamental analysis of Eagle Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Eagle to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.09) | |||
| Jensen Alpha | (0.85) | |||
| Total Risk Alpha | (1.06) | |||
| Treynor Ratio | (0.39) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Eagle Pharmaceuticals. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area. For more information on how to buy Eagle Stock please use our How to Invest in Eagle Pharmaceuticals guide.You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.
Complementary Tools for Eagle Stock analysis
When running Eagle Pharmaceuticals' price analysis, check to measure Eagle Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Eagle Pharmaceuticals is operating at the current time. Most of Eagle Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Eagle Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Eagle Pharmaceuticals' price. Additionally, you may evaluate how the addition of Eagle Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments |
Is Eagle Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Eagle Pharmaceuticals. If investors know Eagle will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Eagle Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.87) | Earnings Share 0.85 | Revenue Per Share 19.684 | Quarterly Revenue Growth (0.13) | Return On Assets 0.0663 |
The market value of Eagle Pharmaceuticals is measured differently than its book value, which is the value of Eagle that is recorded on the company's balance sheet. Investors also form their own opinion of Eagle Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Eagle Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Eagle Pharmaceuticals' market value can be influenced by many factors that don't directly affect Eagle Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Eagle Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Eagle Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Eagle Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.